首页 > 最新文献

Journal of psychosocial oncology research and practice最新文献

英文 中文
Psychosocial factors influencing distress among cancer patients in South India 影响南印度癌症患者痛苦的心理社会因素
Pub Date : 2022-01-01 DOI: 10.1097/OR9.0000000000000067
S. Veeraiah, K. Kayser, R. Sudhakar
Abstract Background: The increase of cancer rates in India over the last decade has placed a significant psychosocial burden on patients and their families. To address the psychosocial issues, cancer centers in India have integrated psychosocial services into cancer care by routinely measuring the distress of patients and responding to their distress. In this study, we sought to determine the association between self-reported distress and patient demographic and clinical variables and awareness of their diagnosis and prognosis. Methods: The Department of Psycho-oncology conducted a cross-sectional, cohort study of patients who were being treated for a variety of cancers in a comprehensive cancer center in Chennai, India. Cancer patients (N = 2019) completed a standardized measure of distress and participated in a clinical interview during their admission to a ward or at the time of referral to psycho-oncology. The level of distress was measured by the NCCN Distress Thermometer and problem list. Chi-square tests were used to examine variations in overall distress. Multi-nominal logistic regression analyses were used to assess the level of patients’ reported distress as a function of clinical characteristics (stage of cancer, awareness of diagnosis and prognosis, physical symptoms). Results: The majority (60.3%) of the sample reported a moderate to high level of emotional distress. There were significant associations (P < .05) of younger age, awareness of diagnosis, prognosis, sleep issues, and physical pain with higher levels of distress. Patients who were aware of their diagnoses were more likely to report moderate (P < .01) or severe distress (P < .05) than those who were unaware. Patients who were aware of their prognoses were less likely to report moderate distress (P < .001) and severe distress (P < .001. Implications for Practice and Research: Given that a majority of patients rated at or above the clinical cut-off for distress, oncology centers in India need to provide training for professional psycho-oncology clinicians and incorporate psycho-oncology services to adequately address patients’ distress. Qualitative research may be needed to advance our understanding of specific social and cultural factors that may influence the psychosocial challenges faced by patients. Further investigation of patient distress related to diagnostic disclosure may be helpful in informing practice.
摘要背景:在过去十年中,印度癌症发病率的上升给患者及其家人带来了巨大的社会心理负担。为了解决心理社会问题,印度癌症中心通过定期测量患者的痛苦并对其痛苦做出反应,将心理社会服务纳入癌症护理。在这项研究中,我们试图确定自我报告的痛苦与患者人口统计学和临床变量以及对其诊断和预后的认识之间的关系。方法:精神科对在印度金奈癌症综合中心接受各种癌症治疗的患者进行了横断面队列研究。癌症患者(N = 2019)完成了痛苦的标准化测量,并在入住病房或转诊至心理肿瘤学时参加了临床访谈。通过NCCN遇险温度计和问题清单测量遇险程度。卡方检验用于检验整体痛苦的变化。多指标逻辑回归分析用于评估患者报告的痛苦程度与临床特征(癌症分期、诊断和预后意识、身体症状)的关系。结果:大多数(60.3%)的样本报告了中度至高度的情绪困扰。有显著的相关性(P < .05)年龄较小,对诊断、预后、睡眠问题和身体疼痛的认识较高。知道自己的诊断的患者更有可能报告中度(P < .01)或严重痛苦(P < .05)比那些不知道的人。了解预后的患者报告中度痛苦的可能性较小(P < .001)和严重痛苦(P < .001.对实践和研究的影响:鉴于大多数患者的痛苦程度达到或超过临床临界值,印度的肿瘤中心需要为专业的心理肿瘤学临床医生提供培训,并纳入心理肿瘤学服务,以充分解决患者的痛苦。可能需要进行定性研究,以加深我们对可能影响患者面临的心理社会挑战的特定社会和文化因素的理解。进一步调查与诊断披露相关的患者痛苦可能有助于为实践提供信息。
{"title":"Psychosocial factors influencing distress among cancer patients in South India","authors":"S. Veeraiah, K. Kayser, R. Sudhakar","doi":"10.1097/OR9.0000000000000067","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000067","url":null,"abstract":"Abstract Background: The increase of cancer rates in India over the last decade has placed a significant psychosocial burden on patients and their families. To address the psychosocial issues, cancer centers in India have integrated psychosocial services into cancer care by routinely measuring the distress of patients and responding to their distress. In this study, we sought to determine the association between self-reported distress and patient demographic and clinical variables and awareness of their diagnosis and prognosis. Methods: The Department of Psycho-oncology conducted a cross-sectional, cohort study of patients who were being treated for a variety of cancers in a comprehensive cancer center in Chennai, India. Cancer patients (N = 2019) completed a standardized measure of distress and participated in a clinical interview during their admission to a ward or at the time of referral to psycho-oncology. The level of distress was measured by the NCCN Distress Thermometer and problem list. Chi-square tests were used to examine variations in overall distress. Multi-nominal logistic regression analyses were used to assess the level of patients’ reported distress as a function of clinical characteristics (stage of cancer, awareness of diagnosis and prognosis, physical symptoms). Results: The majority (60.3%) of the sample reported a moderate to high level of emotional distress. There were significant associations (P < .05) of younger age, awareness of diagnosis, prognosis, sleep issues, and physical pain with higher levels of distress. Patients who were aware of their diagnoses were more likely to report moderate (P < .01) or severe distress (P < .05) than those who were unaware. Patients who were aware of their prognoses were less likely to report moderate distress (P < .001) and severe distress (P < .001. Implications for Practice and Research: Given that a majority of patients rated at or above the clinical cut-off for distress, oncology centers in India need to provide training for professional psycho-oncology clinicians and incorporate psycho-oncology services to adequately address patients’ distress. Qualitative research may be needed to advance our understanding of specific social and cultural factors that may influence the psychosocial challenges faced by patients. Further investigation of patient distress related to diagnostic disclosure may be helpful in informing practice.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"4 1","pages":"e067"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45268787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Antitobacco advertising and lung cancer stigma: a qualitative study of the experiences of people with a lung cancer diagnosis 反烟草广告与癌症耻辱:癌症诊断者经历的定性研究
Pub Date : 2022-01-01 DOI: 10.1097/OR9.0000000000000069
Shiho Rose, A. Boyes, Brian Kelly, P. Bridge, Melissa Carlson, Emily Coutts, C. Paul
Abstract Stigma is often experienced by people affected by lung cancer due to the known links between lung cancer and smoking. Antitobacco campaigns, although attempting to “de-normalise” smoking, may contribute to stigmatising people affected by cancer. The study examined how people diagnosed with lung cancer recall and respond to antitobacco advertisements postdiagnosis. Sixteen qualitative semi-structured interviews were conducted with people with a lung cancer diagnosis who were recruited from an Australian clinical cancer registry. Interviews were analysed using thematic analysis. Participants mostly recalled narrative style antitobacco advertisements. A wide array of emotional responses to the advertisements were reported, including relief, shame, worry, discomfort, and resignation. Some participants avoided the advertisements altogether. Although some participants found the advertisements to be promoting stigma, others did not. Participants were not opposed to the broadcasting of antitobacco advertisements. Rather, the advertisements were perceived as appropriate and necessary. In conclusion, although people diagnosed with lung cancer reported experiencing some negative emotional responses to antitobacco advertising, they were supportive of its continuance.
摘要由于癌症与吸烟之间的已知联系,癌症患者经常遭受耻辱。反烟草运动虽然试图使吸烟“去正常化”,但可能会使癌症患者蒙受耻辱。这项研究调查了被诊断为癌症的人在诊断后如何回忆和回应抗烟草广告。对从澳大利亚癌症临床登记处招募的诊断为癌症的患者进行了16次定性半结构化访谈。访谈采用专题分析法进行分析。参与者大多回忆起叙事风格的反烟草广告。据报道,人们对这些广告产生了广泛的情绪反应,包括宽慰、羞耻、担忧、不适和辞职。一些与会者完全避开了广告。尽管一些参与者认为这些广告宣扬污名,但其他人则不然。与会者并不反对播放反烟草广告。相反,这些广告被认为是适当和必要的。总之,尽管被诊断为癌症的人报告说,他们对抗烟草广告有一些负面的情绪反应,但他们支持其持续存在。
{"title":"Antitobacco advertising and lung cancer stigma: a qualitative study of the experiences of people with a lung cancer diagnosis","authors":"Shiho Rose, A. Boyes, Brian Kelly, P. Bridge, Melissa Carlson, Emily Coutts, C. Paul","doi":"10.1097/OR9.0000000000000069","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000069","url":null,"abstract":"Abstract Stigma is often experienced by people affected by lung cancer due to the known links between lung cancer and smoking. Antitobacco campaigns, although attempting to “de-normalise” smoking, may contribute to stigmatising people affected by cancer. The study examined how people diagnosed with lung cancer recall and respond to antitobacco advertisements postdiagnosis. Sixteen qualitative semi-structured interviews were conducted with people with a lung cancer diagnosis who were recruited from an Australian clinical cancer registry. Interviews were analysed using thematic analysis. Participants mostly recalled narrative style antitobacco advertisements. A wide array of emotional responses to the advertisements were reported, including relief, shame, worry, discomfort, and resignation. Some participants avoided the advertisements altogether. Although some participants found the advertisements to be promoting stigma, others did not. Participants were not opposed to the broadcasting of antitobacco advertisements. Rather, the advertisements were perceived as appropriate and necessary. In conclusion, although people diagnosed with lung cancer reported experiencing some negative emotional responses to antitobacco advertising, they were supportive of its continuance.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"4 1","pages":"e069"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48933150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Qualitative inquiry of cancer caregiving during young adulthood: responsibilities, challenges, teamwork, and social support. 对青年时期癌症护理工作的定性调查:责任、挑战、团队合作和社会支持。
Pub Date : 2021-10-01 Epub Date: 2021-10-25 DOI: 10.1097/or9.0000000000000062
Austin R Waters, Lisa H Gren, Charles R Rogers, Anne C Kirchhoff, Echo L Warner

Background: Young adult cancer caregivers (YACC) may experience heightened caregiver burden because they take on caregiving during a dynamic time of life. The purpose of this study was to describe YACC experiences, burden, and social support while caregiving.

Methods: Grounded by the Cancer Family Caregiving Experience Model and the Stress and Coping Social Support theory, semi-structured interviews were conducted with YACC. Inductive analysis was applied to YACC perceptions of caregiving, and deductive analysis to YACC social networks and social support.

Results: YACC (N=34) were primarily between 25 to 29 years of age (38.2%), primarily female (70.6%), non-Hispanic White (91.2%), employed (85.3%), college graduates or higher (53.0%), and caring for a spouse/partner (52.9%). Qualitative analysis of interviews with YACC resulted in 2 themes: cancer caregiving during young adulthood and young adult cancer caregiver social support. In the first theme YACC often did not perceive themselves as caregivers, rather their caregiving responsibilities were viewed as an extension of their relationship with the patient. Further YACC reported developmental-specific responsibilities (eg, caring for young children, being unable to take time off while solidifying careers) which often conflicted with their caregiving responsibilities (eg, managing patient's medication, attending appointments) and heightened burden. In response, YACC often formed caregiver teams consisting of family, friends, and community members to care for their loved one. In the second theme YACC most commonly reported receiving emotional and instrumental support from their social network. YACC specifically mentioned their appreciation for emotional support provided by other young adults and instrumental support in the form of financial support.

Conclusions: YACC faced developmentally specific challenges during caregiving that older adult caregivers may not encounter. The conflict of young adult and caregiving responsibilities resulted in YACC forming caregiver teams. Thus, theoretical approaches to understand and improve caregiver health would benefit from the inclusion of the developmental context of young adulthood. Furthermore, it is crucial that cancer centers tailor supportive services to YACC as the number of young caregivers increases.

背景:年轻的成年癌症护理者(YACC)可能会承受更重的护理负担,因为他们是在人生的动态时期承担护理工作的。本研究旨在描述青年癌症护理者在护理过程中的经历、负担和社会支持:方法:以癌症家庭护理经验模型和压力与应对社会支持理论为基础,对 YACC 进行了半结构式访谈。对 YACC 的护理感知进行归纳分析,对 YACC 的社会网络和社会支持进行演绎分析:YACC(N=34)的年龄主要在 25 至 29 岁之间(38.2%),主要为女性(70.6%),非西班牙裔白人(91.2%),有工作(85.3%),大学毕业或以上学历(53.0%),照顾配偶/伴侣(52.9%)。通过对 YACC 的访谈进行定性分析,得出了两个主题:青年时期的癌症护理和青年癌症护理者的社会支持。在第一个主题中,青年癌症护理者通常不认为自己是护理者,相反,他们的护理责任被视为他们与病人关系的延伸。此外,青年癌症护理人员还报告了他们在发展过程中的特定责任(例如,照顾年幼的孩子,在巩固职业生涯的同时无法请假),这些责任往往与他们的护理责任(例如,管理病人的药物,参加预约)相冲突,加重了他们的负担。为此,YACC 经常组建由家人、朋友和社区成员组成的护理团队来照顾他们的亲人。在第二个主题中,YACC 最常说的是从他们的社会网络中获得情感和工具支持。YACC 特别提到了他们对其他年轻人提供的情感支持和以经济支持为形式的工具支持的感激之情:青年成人护理员在护理过程中面临着发展方面的特殊挑战,而老年护理员可能不会遇到这些挑战。年轻成人与照护责任之间的冲突导致 YACC 组建了照护者团队。因此,如果能将青年期的发展背景纳入其中,将有助于理解和改善护理者健康的理论方法。此外,随着年轻照顾者人数的增加,癌症中心必须为年轻照顾者提供量身定制的支持性服务。
{"title":"Qualitative inquiry of cancer caregiving during young adulthood: responsibilities, challenges, teamwork, and social support.","authors":"Austin R Waters, Lisa H Gren, Charles R Rogers, Anne C Kirchhoff, Echo L Warner","doi":"10.1097/or9.0000000000000062","DOIUrl":"10.1097/or9.0000000000000062","url":null,"abstract":"<p><strong>Background: </strong>Young adult cancer caregivers (YACC) may experience heightened caregiver burden because they take on caregiving during a dynamic time of life. The purpose of this study was to describe YACC experiences, burden, and social support while caregiving.</p><p><strong>Methods: </strong>Grounded by the Cancer Family Caregiving Experience Model and the Stress and Coping Social Support theory, semi-structured interviews were conducted with YACC. Inductive analysis was applied to YACC perceptions of caregiving, and deductive analysis to YACC social networks and social support.</p><p><strong>Results: </strong>YACC (N=34) were primarily between 25 to 29 years of age (38.2%), primarily female (70.6%), non-Hispanic White (91.2%), employed (85.3%), college graduates or higher (53.0%), and caring for a spouse/partner (52.9%). Qualitative analysis of interviews with YACC resulted in 2 themes: cancer caregiving during young adulthood and young adult cancer caregiver social support. In the first theme YACC often did not perceive themselves as caregivers, rather their caregiving responsibilities were viewed as an extension of their relationship with the patient. Further YACC reported developmental-specific responsibilities (eg, caring for young children, being unable to take time off while solidifying careers) which often conflicted with their caregiving responsibilities (eg, managing patient's medication, attending appointments) and heightened burden. In response, YACC often formed caregiver teams consisting of family, friends, and community members to care for their loved one. In the second theme YACC most commonly reported receiving emotional and instrumental support from their social network. YACC specifically mentioned their appreciation for emotional support provided by other young adults and instrumental support in the form of financial support.</p><p><strong>Conclusions: </strong>YACC faced developmentally specific challenges during caregiving that older adult caregivers may not encounter. The conflict of young adult and caregiving responsibilities resulted in YACC forming caregiver teams. Thus, theoretical approaches to understand and improve caregiver health would benefit from the inclusion of the developmental context of young adulthood. Furthermore, it is crucial that cancer centers tailor supportive services to YACC as the number of young caregivers increases.</p>","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39598562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationships between fear of cancer recurrence, anxiety and worry, and health behaviors and health service use: a systematic review 对癌症复发的恐惧、焦虑和担忧与健康行为和健康服务使用的关系:一项系统综述
Pub Date : 2021-10-01 DOI: 10.1097/OR9.0000000000000064
Sarah C. Reed, Julie Berrett-Abebe, Robin L. Whitney, S. Sarkar, J. Bell
Abstract Background: This systematic review was conducted to improve our understanding of the relationship between fear of cancer recurrence (FCR), anxiety and worry, and engagement in health behaviors and/or health service use. Methods: A systematic review following PRISMA methodology was performed to identify any publications that examined FCR, anxiety and worry, and health behaviors and/or health service use in the following databases: PubMed, CINAHL, and PsychINFO from January 1990 to April 2021. Quality was assessed using QualSyst, a standard quality assessment for evaluating primary research articles. Results: Seventy articles met the inclusion criteria, but the outcomes were too heterogeneous to combine in statistical meta-analysis. The measurement of FCR also varied widely and was inconsistent across studies. Among FCR specific measures, 36% used some version of the Fear of Cancer Recurrence Inventory. Prevention and detection of new and recurrent cancers accounted for 60% of all included studies, with the most frequently examined health behaviors being smoking status (17%) and physical activity (16%). Most associations indicated a significant relationship between FCR and current smoking, with those who are currently smoking experiencing higher levels of FCR. Relatively few studies explored the relationship between FCR and surveillance. Associations categorized under Interventions for Late Effects included a range of health services use with largely mixed results. Overall, studies had moderate to high quality. Conclusions: Given the measurement heterogeneity of FCR, future research would benefit from consistent operationalization and measurement. Some evidence suggests that FCR is associated with poor health behaviors. More studies are needed examining the relationship between FCR and surveillance. Research and clinical interventions may choose to focus on early post-treatment survivorship, given greater opportunities for support and intervention around FCR and other psychosocial concerns.
摘要背景:本系统综述旨在提高我们对癌症复发恐惧(FCR)、焦虑和担忧与健康行为和/或医疗服务使用之间关系的理解。方法:根据PRISMA方法进行系统审查,以确定1990年1月至2021年4月在以下数据库中检查FCR、焦虑和担忧、健康行为和/或医疗服务使用的任何出版物:PubMed、CINAHL和PsychINFO。质量评估使用QualSyst,一种用于评估主要研究文章的标准质量评估。结果:70篇文章符合纳入标准,但结果过于异质,无法在统计荟萃分析中进行组合。FCR的测量也有很大差异,并且在不同的研究中不一致。在针对FCR的测量中,36%的人使用了某种版本的癌症复发恐惧量表。新发和复发癌症的预防和检测占所有纳入研究的60%,最常见的健康行为是吸烟状态(17%)和体育活动(16%)。大多数关联表明FCR与当前吸烟之间存在显著关系,当前吸烟的人FCR水平较高。相对而言,很少有研究探讨FCR与监测之间的关系。根据晚期影响干预措施分类的协会包括一系列医疗服务的使用,结果基本上喜忧参半。总体而言,研究质量从中等到高。结论:鉴于FCR的测量异质性,未来的研究将受益于一致的操作和测量。一些证据表明FCR与不良健康行为有关。需要更多的研究来检验FCR和监测之间的关系。研究和临床干预可能会选择专注于治疗后的早期生存,因为有更多的机会围绕FCR和其他心理社会问题进行支持和干预。
{"title":"Relationships between fear of cancer recurrence, anxiety and worry, and health behaviors and health service use: a systematic review","authors":"Sarah C. Reed, Julie Berrett-Abebe, Robin L. Whitney, S. Sarkar, J. Bell","doi":"10.1097/OR9.0000000000000064","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000064","url":null,"abstract":"Abstract Background: This systematic review was conducted to improve our understanding of the relationship between fear of cancer recurrence (FCR), anxiety and worry, and engagement in health behaviors and/or health service use. Methods: A systematic review following PRISMA methodology was performed to identify any publications that examined FCR, anxiety and worry, and health behaviors and/or health service use in the following databases: PubMed, CINAHL, and PsychINFO from January 1990 to April 2021. Quality was assessed using QualSyst, a standard quality assessment for evaluating primary research articles. Results: Seventy articles met the inclusion criteria, but the outcomes were too heterogeneous to combine in statistical meta-analysis. The measurement of FCR also varied widely and was inconsistent across studies. Among FCR specific measures, 36% used some version of the Fear of Cancer Recurrence Inventory. Prevention and detection of new and recurrent cancers accounted for 60% of all included studies, with the most frequently examined health behaviors being smoking status (17%) and physical activity (16%). Most associations indicated a significant relationship between FCR and current smoking, with those who are currently smoking experiencing higher levels of FCR. Relatively few studies explored the relationship between FCR and surveillance. Associations categorized under Interventions for Late Effects included a range of health services use with largely mixed results. Overall, studies had moderate to high quality. Conclusions: Given the measurement heterogeneity of FCR, future research would benefit from consistent operationalization and measurement. Some evidence suggests that FCR is associated with poor health behaviors. More studies are needed examining the relationship between FCR and surveillance. Research and clinical interventions may choose to focus on early post-treatment survivorship, given greater opportunities for support and intervention around FCR and other psychosocial concerns.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"3 1","pages":"e064"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41985180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The PACT Study: results of a time series study investigating the impact, acceptability and cost of an integrated model for psychosocial screening, care and treatment of patients with urological and head and neck cancers PACT研究:一项时间序列研究的结果,调查了泌尿科和头颈癌患者心理社会筛查、护理和治疗综合模式的影响、可接受性和成本
Pub Date : 2021-10-01 DOI: 10.1097/OR9.0000000000000063
A. Girgis, Hayley Candler, T. Handley, J. Descallar, V. Hansen, M. Haas, R. Viney, P. Haywood, Douglas Bellamy, A. Proietto, B. Kelly
Abstract Background: The significant psychosocial morbidity experienced by cancer patients is often undetected and untreated. Despite international priority given to psychosocial care for cancer patients, implementation of psychosocial programs into routine cancer care is limited. We developed, implemented, and assessed the impact, acceptability, and cost of an integrated, patient-centered Psychosocial Assessment, Care and Treatment (PACT) model of care for cancer patients within a general hospital setting. Methods: A time series research design was implemented to test the PACT model of care, newly introduced in an Australian tertiary hospital. System-level impact on systematic distress screening and management was assessed through audit of the medical records of three cross-sectional samples of 141 patients, at baseline and at 12 and 24 months post-baseline. The impact of the model on patient experience and health care professionals’ (HCPs) knowledge and confidence was assessed via surveys. The acceptability of the intervention was assessed through HCP interviews at 24 months. The cost of the intervention was assessed by PACT staff recording the time spent on care provision, training, and intervention administration, and associated costs were calculated using staff payment rates adjusted for superannuation and leave. Results: Across the 24 months of implementation, formal distress screening increased from 0% at baseline to 29% of patients at 12 months and 31% of patients at 24 months, with an associated decrease in informal screening as formal screening increased. There was no notable change in distress management (ie, development of care plans) across the time period. Baseline patient experience was already high (mean score = 46.85/55) and did not change significantly over the course of the study. In both general and specific areas of addressing patient psychosocial concerns, HCP knowledge and confidence was moderate and remained largely unchanged over the course of the study. HCPs perceived the PACT model as highly beneficial and instrumental in bringing about significant changes to staff's knowledge, practices and awareness of psychosocial issues. The estimated total labor cost (including on-costs) was AUD$119,239 (over the 2 years); with a declining cost over the lifetime of the intervention reflecting the higher initial set-up costs. Conclusions: Although the PACT model was associated with an increase in distress screening, staff workloads, high turnover, and administrative barriers may have restricted the translation into distress management. Future research exploring effective avenues to engage staff at a management level and ensure that staff view distress management as a valuable component of their role may assist to embed strategies into the general hospital culture and lead to more sustainable changes.
摘要背景:癌症患者所经历的显著的心理社会发病率通常未被发现和治疗。尽管国际上优先重视癌症患者的心理社会护理,但在癌症常规护理中实施心理社会方案的情况有限。我们开发、实施并评估了以患者为中心的综合性癌症患者心理社会评估、护理和治疗(PACT)模式的影响、可接受性和成本。方法:采用时间序列研究设计,对澳大利亚一家三级医院新引入的PACT护理模式进行测试。通过对141名患者的三个横断面样本的医疗记录进行审计,评估了系统层面对系统痛苦筛查和管理的影响,这些样本分别位于基线和12岁和24岁 基线后数月。通过调查评估了该模型对患者体验以及医疗保健专业人员(HCP)知识和信心的影响。干预的可接受性通过24岁的HCP访谈进行评估 月。干预成本由PACT工作人员评估,记录在护理、培训和干预管理上花费的时间,相关成本使用根据养老金和休假调整的员工支付率计算。结果:24 实施数月后,正式的痛苦筛查从基线时的0%增加到12岁时的29% 月,31%的患者在24岁时 月,随着正式筛查的增加,非正式筛查的相关减少。在这段时间内,痛苦管理(即制定护理计划)没有显著变化。基线患者体验已经很高(平均得分=46.85/55),并且在研究过程中没有显著变化。在解决患者心理社会问题的一般和特定领域,HCP的知识和信心是适度的,在研究过程中基本保持不变。HCP认为PACT模式非常有益,有助于员工对心理社会问题的知识、实践和意识发生重大变化。预计总人工成本(包括间接成本)为119239澳元(超过2 年);其中在干预的寿命期间成本下降反映了较高的初始设置成本。结论:尽管PACT模型与遇险筛查的增加有关,但工作人员的工作量、高流动性和行政障碍可能限制了转化为遇险管理。未来的研究探索有效途径,让工作人员参与管理层,并确保工作人员将痛苦管理视为其角色的一个宝贵组成部分,这可能有助于将战略融入综合医院文化,并带来更可持续的变革。
{"title":"The PACT Study: results of a time series study investigating the impact, acceptability and cost of an integrated model for psychosocial screening, care and treatment of patients with urological and head and neck cancers","authors":"A. Girgis, Hayley Candler, T. Handley, J. Descallar, V. Hansen, M. Haas, R. Viney, P. Haywood, Douglas Bellamy, A. Proietto, B. Kelly","doi":"10.1097/OR9.0000000000000063","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000063","url":null,"abstract":"Abstract Background: The significant psychosocial morbidity experienced by cancer patients is often undetected and untreated. Despite international priority given to psychosocial care for cancer patients, implementation of psychosocial programs into routine cancer care is limited. We developed, implemented, and assessed the impact, acceptability, and cost of an integrated, patient-centered Psychosocial Assessment, Care and Treatment (PACT) model of care for cancer patients within a general hospital setting. Methods: A time series research design was implemented to test the PACT model of care, newly introduced in an Australian tertiary hospital. System-level impact on systematic distress screening and management was assessed through audit of the medical records of three cross-sectional samples of 141 patients, at baseline and at 12 and 24 months post-baseline. The impact of the model on patient experience and health care professionals’ (HCPs) knowledge and confidence was assessed via surveys. The acceptability of the intervention was assessed through HCP interviews at 24 months. The cost of the intervention was assessed by PACT staff recording the time spent on care provision, training, and intervention administration, and associated costs were calculated using staff payment rates adjusted for superannuation and leave. Results: Across the 24 months of implementation, formal distress screening increased from 0% at baseline to 29% of patients at 12 months and 31% of patients at 24 months, with an associated decrease in informal screening as formal screening increased. There was no notable change in distress management (ie, development of care plans) across the time period. Baseline patient experience was already high (mean score = 46.85/55) and did not change significantly over the course of the study. In both general and specific areas of addressing patient psychosocial concerns, HCP knowledge and confidence was moderate and remained largely unchanged over the course of the study. HCPs perceived the PACT model as highly beneficial and instrumental in bringing about significant changes to staff's knowledge, practices and awareness of psychosocial issues. The estimated total labor cost (including on-costs) was AUD$119,239 (over the 2 years); with a declining cost over the lifetime of the intervention reflecting the higher initial set-up costs. Conclusions: Although the PACT model was associated with an increase in distress screening, staff workloads, high turnover, and administrative barriers may have restricted the translation into distress management. Future research exploring effective avenues to engage staff at a management level and ensure that staff view distress management as a valuable component of their role may assist to embed strategies into the general hospital culture and lead to more sustainable changes.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"3 1","pages":"e063"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44130156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Above and beyond cancer: a novel approach to growth and resilience in cancer survivors 超越癌症:癌症幸存者成长和复原力的新方法
Pub Date : 2021-10-01 DOI: 10.1097/OR9.0000000000000065
Miriam Vélez-Bermúdez, Aleisha Norton, Natalie Ament, J. Armer, Lauren Z Davis, R. L. Deming, S. Lutgendorf
Supplemental Digital Content is available in the text Abstract Background: Although cancer diagnosis and treatment frequently cause distress, many survivors report personal growth, change, and transformation. To better understand these dynamics, we used a qualitative approach to study twenty-seven heterogeneous cancer survivors who participated in physically and emotionally challenging journeys through the Above and Beyond Cancer organization. Groups traveled to Kathmandu (Nepal), Mt. Kilimanjaro (Tanzania), and Mt. Kailash (China), and volunteered at nearby cancer hospitals. Methods: Survivors completed short essays and surveys pre-departure, 3 weeks, and 3 months post-trip. Qualitative responses were categorized into themes by 4 independent reviewers following consensus, and quantitative measures assessed sociodemographic characteristics and mood. Results: Qualitative findings highlighted the role of new experiences and social support in enabling participants to develop new meaning, growth, and a new sense of their capabilities. Quantitative measures showed that anxiety of participants decreased over time. Conclusions: This study points to lifestyle undertakings that can support personal growth in cancer survivors.
摘要背景:尽管癌症的诊断和治疗经常导致痛苦,但许多幸存者报告了个人的成长、变化和转变。为了更好地理解这些动态,我们使用了一种定性方法来研究27名异质性癌症幸存者,他们通过癌症组织参与了身体和情感上具有挑战性的旅程。小组前往加德满都(尼泊尔)、乞力马扎罗山(坦桑尼亚)和凯拉什山(中国),并在附近的癌症医院做志愿者。方法:幸存者在出发前、旅行后3周和3个月完成短文和调查。4名独立评审员根据共识将定性反应分为主题,定量测量评估社会人口特征和情绪。结果:定性研究结果强调了新体验和社会支持在使参与者发展新意义、成长和对自己能力的新感觉方面的作用。定量测量显示,参与者的焦虑随着时间的推移而减少。结论:本研究指出,生活方式事业可以支持癌症幸存者的个人成长。
{"title":"Above and beyond cancer: a novel approach to growth and resilience in cancer survivors","authors":"Miriam Vélez-Bermúdez, Aleisha Norton, Natalie Ament, J. Armer, Lauren Z Davis, R. L. Deming, S. Lutgendorf","doi":"10.1097/OR9.0000000000000065","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000065","url":null,"abstract":"Supplemental Digital Content is available in the text Abstract Background: Although cancer diagnosis and treatment frequently cause distress, many survivors report personal growth, change, and transformation. To better understand these dynamics, we used a qualitative approach to study twenty-seven heterogeneous cancer survivors who participated in physically and emotionally challenging journeys through the Above and Beyond Cancer organization. Groups traveled to Kathmandu (Nepal), Mt. Kilimanjaro (Tanzania), and Mt. Kailash (China), and volunteered at nearby cancer hospitals. Methods: Survivors completed short essays and surveys pre-departure, 3 weeks, and 3 months post-trip. Qualitative responses were categorized into themes by 4 independent reviewers following consensus, and quantitative measures assessed sociodemographic characteristics and mood. Results: Qualitative findings highlighted the role of new experiences and social support in enabling participants to develop new meaning, growth, and a new sense of their capabilities. Quantitative measures showed that anxiety of participants decreased over time. Conclusions: This study points to lifestyle undertakings that can support personal growth in cancer survivors.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"3 1","pages":"e065"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48442328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
We think we can: development of the Dyadic Efficacy Scale for Cancer 我们认为我们可以:开发癌症双重疗效量表
Pub Date : 2021-10-01 DOI: 10.1097/OR9.0000000000000066
D. C. Brosseau, J. Braeken, C. Carmack, Z. Rosberger, A. Körner
Supplemental Digital Content is available in the text Abstract Background: Measurement advances are needed to enable the study of dyadic-level processes impacting couples coping with cancer. This study sought to develop and empirically examine a Dyadic Efficacy Scale for Cancer (DESC). Cancer-related dyadic efficacy is an individual's confidence to work together with a partner to cope with cancer and its treatment. Methods: The DESC was developed using an exploratory sequential mixed methods design. This paper outlines the psychometric evaluation phase. Individuals with cancer (N = 261) and their partners (N = 217) completed 50 items. Item-level analyses reduced this set to 26 items. Using the dyad as the unit of analysis, confirmatory factor analysis with mirrored patient and partner bifactor structure tested for the presence of a general factor and 3 secondary factors, that is, illness intrusions, patient affect, partner affect. Results: Goodness-of-fit indices supported the identified model, χ 2(1170) = 2090, P < .001; RMSEA = .05, P = .14, 90% CI .05–.06; SRMR = .05; CFI = .90. Multidimensionality differed for patients and partners. A general dyadic efficacy factor and secondary factors for managing affect were present for both dyad members, whereas the secondary factor of managing illness intrusions was confirmed for patients only. The model explained 72% and 64% of the variance in patients’ and partners’ dyadic efficacy. Evidence of convergent validity was presented. Conclusions: This study is the first to provide a tool to assess dyadic efficacy among couples coping with cancer. The assessment of cancer-related dyadic efficacy enables new discoveries into couples’ adjustment to cancer.
摘要背景:为了研究影响夫妻应对癌症的二元水平过程,需要在测量方面取得进展。本研究旨在开发和实证检验癌症双重疗效量表(DESC)。癌症相关的二元疗效是一个人与伴侣一起应对癌症及其治疗的信心。方法:采用探索性顺序混合方法设计DESC。本文概述了心理测量评价阶段。癌症患者(N = 261)和他们的伴侣(N = 217)完成了50个项目。项目层面的分析将这个集合减少到26个项目。以二分体为分析单元,采用镜像患者与伴侣双因素结构的验证性因素分析,检验是否存在1个一般因素和3个次要因素,即疾病侵入、患者影响、伴侣影响。结果:拟合优度指数支持鉴定的模型,χ 2(1170) = 2090, P < .001;rmsea =。05, p =。14, 90% ci 0.05 - 0.06;srmr = .05;cfi = 0.90。患者和伴侣的多维度存在差异。两组成员均存在一般的二元效能因子和管理情绪的次要因子,而管理疾病侵扰的次要因子仅在患者中得到证实。该模型解释了72%和64%的患者和伴侣的双重疗效差异。提出了收敛效度的证据。结论:这项研究首次提供了一种工具来评估夫妻应对癌症的双重疗效。对癌症相关的二元疗效的评估使夫妇对癌症的适应有了新的发现。
{"title":"We think we can: development of the Dyadic Efficacy Scale for Cancer","authors":"D. C. Brosseau, J. Braeken, C. Carmack, Z. Rosberger, A. Körner","doi":"10.1097/OR9.0000000000000066","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000066","url":null,"abstract":"Supplemental Digital Content is available in the text Abstract Background: Measurement advances are needed to enable the study of dyadic-level processes impacting couples coping with cancer. This study sought to develop and empirically examine a Dyadic Efficacy Scale for Cancer (DESC). Cancer-related dyadic efficacy is an individual's confidence to work together with a partner to cope with cancer and its treatment. Methods: The DESC was developed using an exploratory sequential mixed methods design. This paper outlines the psychometric evaluation phase. Individuals with cancer (N = 261) and their partners (N = 217) completed 50 items. Item-level analyses reduced this set to 26 items. Using the dyad as the unit of analysis, confirmatory factor analysis with mirrored patient and partner bifactor structure tested for the presence of a general factor and 3 secondary factors, that is, illness intrusions, patient affect, partner affect. Results: Goodness-of-fit indices supported the identified model, χ 2(1170) = 2090, P < .001; RMSEA = .05, P = .14, 90% CI .05–.06; SRMR = .05; CFI = .90. Multidimensionality differed for patients and partners. A general dyadic efficacy factor and secondary factors for managing affect were present for both dyad members, whereas the secondary factor of managing illness intrusions was confirmed for patients only. The model explained 72% and 64% of the variance in patients’ and partners’ dyadic efficacy. Evidence of convergent validity was presented. Conclusions: This study is the first to provide a tool to assess dyadic efficacy among couples coping with cancer. The assessment of cancer-related dyadic efficacy enables new discoveries into couples’ adjustment to cancer.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"3 1","pages":"e066"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45534248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
From ideal to actual practice: Tailoring a clinical pathway to address anxiety or depression in patients with cancer and planning its implementation across individual clinical services 从理想到实际:定制临床途径,以解决癌症患者的焦虑或抑郁,并规划其在个人临床服务中的实施
Pub Date : 2021-10-01 DOI: 10.1097/OR9.0000000000000061
P. Butow, H. Shepherd, J. Cuddy, M. Harris, S. He, L. Masya, N. Rankin, P. Grimison, A. Girgis, J. Shaw
Supplemental Digital Content is available in the text Abstract Introduction: Clinical pathways (CPs) can improve health outcomes, but evidence of their impact is mixed, perhaps due to variations in CP delivery. Identifying why variations occur, and their intended purpose is important, to guide CP development and implementation. We developed a CP for screening, assessment and management of anxiety and depression in cancer patients (the ADAPT CP). The CP was implemented in 12 Oncology services in Australia that were participating in the ADAPT Cluster randomized controlled trial (CRCT), allowing some tailoring of the CP for local conditions. The aim of this article is to describe what and why decisions were made to tailor the ADAPT CP in these services. Method: Twelve oncology services were purposively selected for diversity in setting. At each service, a multi-disciplinary lead team was formed to make decisions about local tailoring and to plan, champion and enact the CP implementation. Detailed notes taken during engagement meetings, and service-specific workflow diagrams, form the data for this analysis. Notes were content-analyzed, and workflows reviewed, to identify decision-making themes. Results: Twelve cancer services (7 urban and 5 regional) participated in CRCT. Ten were publicly funded, one was privately funded and the other was a mixed public and private service. Diverse decisions were made regarding the selection of eligible patient cohorts, how to introduce screening to patients, and screening and triage processes. Rationales for decisions included aligning with existing workflows, utilizing staff with required skills, minimizing staff burden, ensuring no patient was missed, and minimizing patient distress. Discussion: Practical issues and staff attitudes and skills often guided CP decisions, highlighting the need to work collaboratively with health services to determine the optimal workflow for each setting. In some settings, considerable discussion and problem-solving was required before processes could be agreed upon that overcame perceived barriers and allowed the CP implementation to proceed. Although it is yet to be determined whether some decisions were optimal in terms of patient outcomes, local tailoring ensured the CP became operational at all services. Allowing time and ensuring the right people are involved are essential when tailoring new CPs before their introduction into clinical care.
补充的数字内容可在文本中获得摘要简介:临床途径(CP)可以改善健康结果,但其影响的证据喜忧参半,可能是由于CP提供的差异。识别变异发生的原因及其预期目的对于指导CP的开发和实施非常重要。我们开发了一种用于癌症患者焦虑和抑郁的筛查、评估和管理的CP(ADAPT CP)。CP在澳大利亚的12家肿瘤服务机构实施,这些机构参与了ADAPT集群随机对照试验(CRCT),允许根据当地情况对CP进行一些调整。本文的目的是描述在这些服务中定制ADAPT CP的决策内容和原因。方法:有针对性地选择了12家肿瘤服务机构,以实现环境的多样性。在每项服务中,都成立了一个多学科领导团队,负责就本地定制做出决定,并计划、支持和实施CP。参与会议期间所做的详细笔记以及特定服务的工作流程图构成了此分析的数据。对笔记进行了内容分析和工作流程审查,以确定决策主题。结果:12个癌症服务机构(7个城市和5个地区)参加了CRCT。10个是公共资助的,一个是私人资助的,另一个是公共和私人混合服务。在选择符合条件的患者队列、如何向患者介绍筛查以及筛查和分诊过程方面做出了不同的决定。决策的理由包括与现有工作流程保持一致,利用具有所需技能的员工,最大限度地减少员工负担,确保没有遗漏患者,以及最大限度地减轻患者痛苦。讨论:实际问题以及工作人员的态度和技能通常指导CP的决策,强调需要与卫生服务部门合作,以确定每个环境的最佳工作流程。在某些情况下,需要进行大量的讨论和解决问题,然后才能就克服感知障碍并允许CP实施的流程达成一致。尽管就患者结果而言,一些决策是否是最佳的尚待确定,但局部定制确保了CP在所有服务中都能运行。在将新的CP引入临床护理之前,留出时间并确保合适的人参与进来是至关重要的。
{"title":"From ideal to actual practice: Tailoring a clinical pathway to address anxiety or depression in patients with cancer and planning its implementation across individual clinical services","authors":"P. Butow, H. Shepherd, J. Cuddy, M. Harris, S. He, L. Masya, N. Rankin, P. Grimison, A. Girgis, J. Shaw","doi":"10.1097/OR9.0000000000000061","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000061","url":null,"abstract":"Supplemental Digital Content is available in the text Abstract Introduction: Clinical pathways (CPs) can improve health outcomes, but evidence of their impact is mixed, perhaps due to variations in CP delivery. Identifying why variations occur, and their intended purpose is important, to guide CP development and implementation. We developed a CP for screening, assessment and management of anxiety and depression in cancer patients (the ADAPT CP). The CP was implemented in 12 Oncology services in Australia that were participating in the ADAPT Cluster randomized controlled trial (CRCT), allowing some tailoring of the CP for local conditions. The aim of this article is to describe what and why decisions were made to tailor the ADAPT CP in these services. Method: Twelve oncology services were purposively selected for diversity in setting. At each service, a multi-disciplinary lead team was formed to make decisions about local tailoring and to plan, champion and enact the CP implementation. Detailed notes taken during engagement meetings, and service-specific workflow diagrams, form the data for this analysis. Notes were content-analyzed, and workflows reviewed, to identify decision-making themes. Results: Twelve cancer services (7 urban and 5 regional) participated in CRCT. Ten were publicly funded, one was privately funded and the other was a mixed public and private service. Diverse decisions were made regarding the selection of eligible patient cohorts, how to introduce screening to patients, and screening and triage processes. Rationales for decisions included aligning with existing workflows, utilizing staff with required skills, minimizing staff burden, ensuring no patient was missed, and minimizing patient distress. Discussion: Practical issues and staff attitudes and skills often guided CP decisions, highlighting the need to work collaboratively with health services to determine the optimal workflow for each setting. In some settings, considerable discussion and problem-solving was required before processes could be agreed upon that overcame perceived barriers and allowed the CP implementation to proceed. Although it is yet to be determined whether some decisions were optimal in terms of patient outcomes, local tailoring ensured the CP became operational at all services. Allowing time and ensuring the right people are involved are essential when tailoring new CPs before their introduction into clinical care.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"3 1","pages":"e061"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49076570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Decision-making context of women who have undergone surgical treatment for breast cancer: a qualitative exploration of patient perspectives 接受乳腺癌手术治疗的女性的决策背景:对患者观点的定性探索
Pub Date : 2021-07-01 DOI: 10.1097/OR9.0000000000000057
Georgia Darmonkow, E. Dicks, R. Roome, J. Chafe, C. Simmonds, H. Etchegary
Background: Mastectomy (MT) rates are higher in Newfoundland and Labrador (NL) than in any other province in Canada, even in women diagnosed with early-stage breast cancer. In this article, we present qualitative data from women who made a surgical breast cancer treatment decision to better understand the decision-making environment and process. Methods: A descriptive, qualitative design was employed. Semi-structured interviews and focus groups were held with women in NL who underwent surgical treatment for breast cancer, including breast-conserving surgery (BCS) or mastectomy (MT). Results: Thirty-five women participated. 74.3% had MT, whereas only 11.4% had BCS. Additionally, 14.3% had BCS initially followed by MT. The surgical treatment decision-making context was heterogeneous. Women reported varying levels of time they had to make a surgical decision, diverse perceptions of decisional choice, opinions on the adequacy of information provided to inform a decision, and different levels of available formal and informal supports. Most reported they were satisfied with their surgical decision, although the context in which these decisions were made was clearly a challenging one. Conclusions: Although most women were pleased with the surgical care they received, adequate time and thorough pre-surgical discussion were noted as necessary but not always available. Women explained the importance of thinking through their personal circumstances and values so as to make informed surgical decisions. Postsurgical care and discussion of available psychosocial supports were proposed as areas that could be improved.
背景:纽芬兰和拉布拉多省(NL)的乳房切除术(MT)率高于加拿大任何其他省份,即使在诊断为早期乳腺癌的妇女中也是如此。在这篇文章中,我们从做出手术乳腺癌治疗决定的妇女中提供定性数据,以更好地了解决策环境和过程。方法:采用描述性、定性设计。对NL接受乳腺癌手术治疗的妇女进行半结构化访谈和焦点小组,包括保乳手术(BCS)或乳房切除术(MT)。结果:35名女性参与。74.3%的人有MT,而只有11.4%的人有BCS。此外,14.3%的患者最初有BCS,随后有MT。手术治疗决策背景是不同的。妇女报告说,她们必须在不同程度上作出手术决定,对决定选择的不同看法,对提供的信息是否足够作出决定的意见,以及可获得的正式和非正式支持的不同程度。大多数人报告说他们对自己的手术决定感到满意,尽管做出这些决定的背景显然是一个具有挑战性的。结论:尽管大多数妇女对她们接受的手术护理感到满意,但充分的时间和彻底的术前讨论是必要的,但并非总是如此。妇女们解释了考虑她们的个人情况和价值观以便做出明智的手术决定的重要性。建议术后护理和讨论可用的社会心理支持作为可以改进的领域。
{"title":"Decision-making context of women who have undergone surgical treatment for breast cancer: a qualitative exploration of patient perspectives","authors":"Georgia Darmonkow, E. Dicks, R. Roome, J. Chafe, C. Simmonds, H. Etchegary","doi":"10.1097/OR9.0000000000000057","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000057","url":null,"abstract":"Background: Mastectomy (MT) rates are higher in Newfoundland and Labrador (NL) than in any other province in Canada, even in women diagnosed with early-stage breast cancer. In this article, we present qualitative data from women who made a surgical breast cancer treatment decision to better understand the decision-making environment and process. Methods: A descriptive, qualitative design was employed. Semi-structured interviews and focus groups were held with women in NL who underwent surgical treatment for breast cancer, including breast-conserving surgery (BCS) or mastectomy (MT). Results: Thirty-five women participated. 74.3% had MT, whereas only 11.4% had BCS. Additionally, 14.3% had BCS initially followed by MT. The surgical treatment decision-making context was heterogeneous. Women reported varying levels of time they had to make a surgical decision, diverse perceptions of decisional choice, opinions on the adequacy of information provided to inform a decision, and different levels of available formal and informal supports. Most reported they were satisfied with their surgical decision, although the context in which these decisions were made was clearly a challenging one. Conclusions: Although most women were pleased with the surgical care they received, adequate time and thorough pre-surgical discussion were noted as necessary but not always available. Women explained the importance of thinking through their personal circumstances and values so as to make informed surgical decisions. Postsurgical care and discussion of available psychosocial supports were proposed as areas that could be improved.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"3 1","pages":"e057"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44576419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Does undertaking genome sequencing prompt actual and planned lifestyle-related behavior change in cancer patients and survivors? A qualitative study 进行基因组测序是否会促使癌症患者和幸存者实际和计划的生活方式相关的行为改变?定性研究
Pub Date : 2021-07-01 DOI: 10.1097/OR9.0000000000000059
Sabina Vatter, N. Bartley, M. Best, I. Juraskova, C. Jacobs, M. Ballinger, David M. Thomas, P. Butow
Abstract Background: In order for genomic testing to fulfil its promise of helping cancer patients and survivors to prevent future disease, it is important to consider its behavioral impact and outcomes. This study explored the factors that participants perceived would impact lifestyle-related behavioral intentions following genome sequencing (GS). Methods: Individual semistructured interviews were conducted to explore behavioral intentions with a purposive subsample of 24 adults with a past or current cancer of likely heritable aetiology who undertook germline GS as part of a larger genetic study (RisC). Participants were interviewed 12 months following their consent to a longitudinal psychosocial sub-study of RisC (PiGeOn study), before receipt of results. Data were analyzed using thematic analysis. Results: Analysis revealed 3 main themes: past prompts, barriers, and motivators to behavior change. The primary goal for behavioral change was to be healthy for oneself and one's family. Past experience of cancer facilitated positive modifications to lifestyle, such as increased exercise and healthy diet, higher prioritization of mental health and well-being, and regular health check-ups and tests. Maintaining these changes, however, was difficult for some due to daily commitments and lack of self-control. Limited knowledge and perceived inevitability of developing cancer due to genetic predisposition were recognized as barriers to making lifestyle changes. Concurrently, future receipt of actionable results was perceived as a powerful driver of behavior change. Conclusion: Understanding barriers and facilitators to behavior intention and patients’ attitudes to recommended lifestyle change in the context of genomic testing can be useful for health care professionals, to guide their discussions of behavioral change.
{"title":"Does undertaking genome sequencing prompt actual and planned lifestyle-related behavior change in cancer patients and survivors? A qualitative study","authors":"Sabina Vatter, N. Bartley, M. Best, I. Juraskova, C. Jacobs, M. Ballinger, David M. Thomas, P. Butow","doi":"10.1097/OR9.0000000000000059","DOIUrl":"https://doi.org/10.1097/OR9.0000000000000059","url":null,"abstract":"Abstract Background: In order for genomic testing to fulfil its promise of helping cancer patients and survivors to prevent future disease, it is important to consider its behavioral impact and outcomes. This study explored the factors that participants perceived would impact lifestyle-related behavioral intentions following genome sequencing (GS). Methods: Individual semistructured interviews were conducted to explore behavioral intentions with a purposive subsample of 24 adults with a past or current cancer of likely heritable aetiology who undertook germline GS as part of a larger genetic study (RisC). Participants were interviewed 12 months following their consent to a longitudinal psychosocial sub-study of RisC (PiGeOn study), before receipt of results. Data were analyzed using thematic analysis. Results: Analysis revealed 3 main themes: past prompts, barriers, and motivators to behavior change. The primary goal for behavioral change was to be healthy for oneself and one's family. Past experience of cancer facilitated positive modifications to lifestyle, such as increased exercise and healthy diet, higher prioritization of mental health and well-being, and regular health check-ups and tests. Maintaining these changes, however, was difficult for some due to daily commitments and lack of self-control. Limited knowledge and perceived inevitability of developing cancer due to genetic predisposition were recognized as barriers to making lifestyle changes. Concurrently, future receipt of actionable results was perceived as a powerful driver of behavior change. Conclusion: Understanding barriers and facilitators to behavior intention and patients’ attitudes to recommended lifestyle change in the context of genomic testing can be useful for health care professionals, to guide their discussions of behavioral change.","PeriodicalId":73915,"journal":{"name":"Journal of psychosocial oncology research and practice","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87350226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of psychosocial oncology research and practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1